Blood Disorders Resource Center

Ringing the Ceremonial “Cancer Bell” Following a Course of Treatment May Have Unintended Consequences on Patients

Blood Cancer Awareness Month Spotlights Hematologic Cancers

Did you know September is Blood Cancer Awareness Month? This month, take the time to learn more about this disease, which impacts more than...

Vadadustat for Anemia in Patients with Chronic Kidney Disease

Anemia is a common complication of chronic kidney disease (CKD) and is associated with a reduced health-related quality of life, an increase in the...
hematology oncology news cancer news

Hem/Onc Roundup: Optimizing Treatment for Childhood Leukemia, New ASCO Guidelines, and More

Each week on DocWire, editors bring you the latest news and research in hematology and oncology. Here are this week's top headlines: Expert Discusses Phenotypic...

Roxadustat versus Epoetin Alfa: Pooled Results from Phase 3 Studies

During a virtual poster session at the NKF Spring Clinical Meetings 2021, Robert Provenzano, MD, and colleagues reported pooled results from phase 3 studies...

Anemia and Hepcidin Concentration in Hemodialysis Patients

Patients on hemodialysis often develop anemia due to hypoerythropoiesis and chronic inflammation. The hormone hepcidin regulates iron homeostasis and is an indicator of iron...

Anemia in Peritoneal Dialysis Patients in the Asia-Pacific Region

Patients with chronic kidney disease commonly develop anemia. For patients with end-stage kidney disease, peritoneal dialysis is a common modality of kidney replacement therapy,...

ESA Use in Patients with Non-Dialysis Dependent CKD

NKF Spring Clinical Meetings Patients with non-dialysis dependent chronic kidney disease (NDD-CKD) commonly develop anemia. Since the 1980s, erythropoiesis-stimulating agents (ESAs) have been approved for...

Curated Journal Reading List